Allan C. Golston
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Harley-Davidson Shares Rise on Citigroup Upgrade. Harley-Davidson stock jumped 10% after Citigroup upgraded the company to Buy from Neutral. The bank cited a potential multi-year retail growth story for the motorcycle maker. The stock is now trading near its 52-week high, with an average analyst target of $27.90.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Stryker's $400M Robotics Deal and FDA Clearance of Sonopet 3. Stryker announced a $400 million agreement to expand its robotics portfolio, detailing the technologies and capabilities it will acquire. In a separate update, the company received FDA clearance for the Sonopet 3, a new tool within its surgical platform. Both moves broaden Stryker’s product range and may support future revenue growth. The developments come as the stock trades near its recent support level.
Transaction History
| TROW | ▲ Buy | Grant | 61 | $6K | 9/29/2026 | View on chart |
| TROW | ▲ Buy | Grant | 55 | $6K | 6/29/2026 | View on chart |
| HOG | ▲ Buy | Option Exercise | 3,008 | $0 | 5/14/2026 | View on chart |
| TROW | ▲ Buy | Grant | 1,899 | $0 | 5/8/2026 | View on chart |
| TROW | ▲ Buy | Grant | 42 | $4K | 3/30/2026 | View on chart |
| TROW | ▲ Buy | Grant | 35 | $4K | 12/30/2025 | View on chart |
| TROW | ▲ Buy | Grant | 2,859 | $0 | 10/28/2025 | View on chart |
| HOG | ▲ Buy | Option Exercise | 2,095 | $0 | 5/16/2025 | View on chart |
| SYK | ▲ Buy | Option Exercise | 3,605 | $442K | 2/18/2025 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 1,147 | $442K | 2/18/2025 | View on chart |
| SYK | ▼ Sell | Open Market | 2,458 | $942K | 2/18/2025 | View on chart |
| HOG | ▲ Buy | Option Exercise | 2,207 | $0 | 5/17/2024 | View on chart |
| SYK | ▲ Buy | Grant | 653 | $0 | 5/9/2024 | View on chart |
| SYK | ▲ Buy | Option Exercise | 4,570 | $442K | 2/2/2024 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 1,297 | $442K | 2/2/2024 | View on chart |
| SYK | ▼ Sell | Open Market | 3,273 | $1.1M | 2/2/2024 | View on chart |
| SYK | ▲ Buy | Grant | 705 | $0 | 5/10/2023 | View on chart |
| SYK | ▲ Buy | Option Exercise | 3,795 | $353K | 2/28/2023 | View on chart |
| SYK | ▲ Buy | Option Exercise | 4,355 | $353K | 2/28/2023 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 2,691 | $707K | 2/28/2023 | View on chart |
| SYK | ▼ Sell | Open Market | 5,459 | $1.4M | 2/28/2023 | View on chart |
| SYK | ▲ Buy | Option Exercise | 693 | $0 | 5/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
T. Rowe Price Faces Advisor Hiring Push and Dividend Debate
T. Rowe Price is testing its growth strategy with a new advisor hiring push, while analysts note a modest fair‑value cut amid mixed views. The firm’s dividend yield of 4.97% keeps it in the conversation with other dividend leaders, and a recent 38% share drop has led some to label it undervalued. Earnings expectations are being watched closely as the company prepares its next quarterly report.
T. Rowe Price Faces Advisor Hiring Push and Dividend Debate. T. Rowe Price is testing its growth strategy with a new advisor hiring push, while analysts note a modest fair‑value cut amid mixed views. The firm’s dividend yield of 4.97% keeps it in the conversation with other dividend leaders, and a recent 38% share drop has led some to label it undervalued. Earnings expectations are being watched closely as the company prepares its next quarterly report.